Teladoc (NYSE:TDOC) Q3 results:
Revenues: $138.0M (+24.3%); access fee revenue: $119.1M (+23.4%).
Paid visits: 14,142 (24.8%).
Net loss: ($20.3M) (+12.9%); loss/share: ($0.28) (+17.6%).
Cash flow ops (9 mo.): $11.7M (+260.1%).
Q4 guidance: Revenue: $149M – 153M; non-GAAP EBITDA: $11.5M – 15.5M; total visits: 1.0M – 1.2M.
2019 guidance: Revenue: $546M – 550M from $538M – 545M; non-GAAP EBITDA: $28M – 32M from $27M – 33M; total visits: 3.9M – 4.1M from 3.7M – 4.0M.
Previously: Teladoc Health EPS beats by $0.12, beats on revenue (Oct. 30)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.